Geneos Wealth Management’s Meta Materials Inc. Common Stock MMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-50
Closed -$5K 2660
2022
Q2
$5K Hold
50
﹤0.01% 2219
2022
Q1
$8K Buy
+50
New +$9.31K ﹤0.01% 2193
2021
Q2
Sell
-50
Closed -$21K 3162
2021
Q1
$21K Hold
50
﹤0.01% 2068
2020
Q4
$18K Hold
50
﹤0.01% 1980
2020
Q3
$2K Hold
50
﹤0.01% 2464
2020
Q2
$3K Hold
50
﹤0.01% 2317
2020
Q1
$4K Hold
50
﹤0.01% 2136
2019
Q4
$8K Hold
50
﹤0.01% 2077
2019
Q3
$11K Hold
50
﹤0.01% 1874
2019
Q2
$14K Hold
50
﹤0.01% 1796
2019
Q1
$16K Hold
50
﹤0.01% 1682
2018
Q4
$5K Hold
50
﹤0.01% 2010
2018
Q3
$9K Hold
50
﹤0.01% 1897
2018
Q2
$13K Hold
50
﹤0.01% 1620
2018
Q1
$13K Hold
50
﹤0.01% 1559
2017
Q4
$13K Hold
50
﹤0.01% 1550
2017
Q3
$12K Hold
50
﹤0.01% 1526
2017
Q2
$16K Hold
50
﹤0.01% 1369
2017
Q1
$14K Buy
+50
New +$14.7K ﹤0.01% 1382
2016
Q4
Hold
0
1416

Other funds holding MMAT

Geneos Wealth Management's MMAT Position: Q3 2022 in Review

Geneos Wealth Management sold out of Meta Materials Inc. Common Stock (MMAT) in Q3 2022, closing a stake of 50 shares — an estimated $5K sold.

Geneos Wealth Management first reported a position in MMAT in Q1 2017 and held it in 19 quarters. The position peaked at $21K in Q1 2021. 95 funds tracked by Wall St. Rank hold MMAT as of Q3 2022.

  • Geneos Wealth Management reported no remaining Meta Materials Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 50 Meta Materials Inc. Common Stock shares in Q3 2022, an estimated $5K.
  • Geneos Wealth Management first reported a position in Meta Materials Inc. Common Stock in Q1 2017 and held it in 19 quarters.
  • Geneos Wealth Management's Meta Materials Inc. Common Stock position peaked at $21K in Q1 2021.
  • 95 funds tracked by Wall St. Rank held Meta Materials Inc. Common Stock as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.